Various forms of immunotherapy, including oral immunotherapy (OIT) and sublingual immunotherapy (SLIT), are being more frequently used since both modalities have proven to be promising and effective in children with IgE-mediated, challenge-proven peanut allergy (80, 100–102). The gene discussed is IGHE; the disease is peanut allergic reaction.